Genmab (United States)

243 papers and 7.7k indexed citations i.

About

In recent decades, authors affiliated with Genmab (United States) have published 243 papers, which have received a total of 7.7k indexed citations. Scholars at this organization have produced 130 papers in Oncology, 108 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Pathology and Forensic Medicine on the topics of Monoclonal and Polyclonal Antibodies Research (95 papers), CAR-T cell therapy research (76 papers) and Lymphoma Diagnosis and Treatment (55 papers). Their work is cited by papers focused on Immunology (2.8k citations), Radiology, Nuclear Medicine and Imaging (2.6k citations) and Molecular Biology (2.1k citations). Authors at Genmab (United States) collaborate with scholars in United States, The Netherlands and Denmark and have published in prestigious journals including Nature, Science and The Lancet. Some of Genmab (United States)'s most productive authors include Paul W.H.I. Parren, Jan G. J. van de Winkel, Janine Schuurman, Frank J. Beurskens and Wim K. Bleeker.

In The Last Decade

Fields of papers published by authors at Genmab (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Genmab (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Genmab (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Genmab (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Genmab (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genmab (United States) more than expected).

Rankless by CCL
2025